Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI – Get Free Report) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 1,700 shares, a growth of 88.9% from the February 13th total of 900 shares. Based on an average daily volume of 11,800 shares, the short-interest ratio is currently 0.1 days. Currently, 0.5% of the shares of the stock are short sold.
Scinai Immunotherapeutics Trading Up 0.5 %
Shares of Scinai Immunotherapeutics stock opened at $3.35 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.16 and a quick ratio of 1.16. Scinai Immunotherapeutics has a 1 year low of $2.23 and a 1 year high of $8.92. The firm has a market cap of $2.85 million, a PE ratio of -0.01 and a beta of 2.36. The company has a 50 day simple moving average of $3.46 and a two-hundred day simple moving average of $3.48.
About Scinai Immunotherapeutics
Read More
- Five stocks we like better than Scinai Immunotherapeutics
- Investing in the High PE Growth Stocks
- How to Build the Ultimate Everything ETF Portfolio
- What Are Growth Stocks and Investing in Them
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Scinai Immunotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scinai Immunotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.